A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, adult participants with severe renal impairment, and participants with end-stage renal disease.
Eligibility
Sex
ALL
Min age
18 Years
Max age
84 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Participant must have severe renal impairment (RI).
* Participant must have end-stage renal disease (ESRD).
* Participant must be healthy male and female participants not of childbearing potential between 18 and 84 years of age (inclusive) with a BMI between 18 and 40 kg/m2, (inclusive) at screening.
Exclusion Criteria:
* Any surgical or medical condition possibly affecting drug absorption, distribution, metabolism, and excretion (ADME).
* Any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the participant from participating in the study
* Known or suspected active autoimmune disorder, or any history of known or suspected congenital or acquired immunodeficiency state or condition that would compromise the participant's immune status
* Other protocol-defined inclusion/exclusion criteria apply.
Primary outcome measure(s)
Maximum observed concentration (Cmax) — Up to Day 44
Time of maximum observed plasma concentration (Tmax) — Up to Day 44
Area under the plasma concentration-time curve from time zero to time of last quantifiable concentration (AUC(0-T)) — Up to Day 44
Area under the plasma concentration-time curve from time zero extrapolated to infinite time (AUC(INF)) — Up to Day 44
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.